| Year |
Citation |
Score |
| 2014 |
Drye LT, Casper AS, Sternberg AL, Holbrook JT, Jenkins G, Meinert CL. The transitioning from trials to extended follow-up studies. Clinical Trials (London, England). 11: 635-47. PMID 25115882 DOI: 10.1177/1740774514547396 |
0.542 |
|
| 2014 |
Drye LT, Casper AS, Sternberg AL, Holbrook JT, Jenkins G, Meinert CL. The transitioning from trials to extended follow-up studies Clinical Trials. 11: 635-647. DOI: 10.1177/1740774514547396 |
0.496 |
|
| 2009 |
Beasley JM, Ange BA, Anderson CA, Miller ER, Erlinger TP, Holbrook JT, Sacks FM, Appel LJ. Associations between macronutrient intake and self-reported appetite and fasting levels of appetite hormones: results from the Optimal Macronutrient Intake Trial to Prevent Heart Disease. American Journal of Epidemiology. 169: 893-900. PMID 19224977 DOI: 10.1093/Aje/Kwn415 |
0.513 |
|
| 2009 |
Beasley JM, Ange BA, Anderson CA, Miller Iii ER, Holbrook JT, Appel LJ. Characteristics associated with fasting appetite hormones (obestatin, ghrelin, and leptin). Obesity (Silver Spring, Md.). 17: 349-54. PMID 19057526 DOI: 10.1038/Oby.2008.551 |
0.527 |
|
| 2009 |
Puhan MA, Dickersin K, Ervin A, Holbrook J, Li T, Scherer R, Ssemanda E, Vedula S. Wiley Encyclopedia of Clinical Trials: Edited by Ralph B. D'Agostino, Lisa Sullivan, and Joseph Massaro American Journal of Epidemiology. 170: 665-666. DOI: 10.1093/Aje/Kwp241 |
0.61 |
|
| 2007 |
Jabs DA, Van Natta ML, Holbrook JT, Kempen JH, Meinert CL, Davis MD. Longitudinal study of the ocular complications of AIDS: 1. Ocular diagnoses at enrollment. Ophthalmology. 114: 780-6. PMID 17258320 DOI: 10.1016/J.Ophtha.2006.11.008 |
0.494 |
|
| 2007 |
Jabs DA, Van Natta ML, Holbrook JT, Kempen JH, Meinert CL, Davis MD. Longitudinal study of the ocular complications of AIDS: 2. Ocular examination results at enrollment. Ophthalmology. 114: 787-93. PMID 17210182 DOI: 10.1016/J.Ophtha.2006.07.065 |
0.534 |
|
| 2007 |
Thorne JE, Holbrook JT, Jabs DA, Kempen JH, Nichols C, Meinert CL. Effect of cytomegalovirus retinitis on the risk of visual acuity loss among patients with AIDS. Ophthalmology. 114: 591-8. PMID 17123624 DOI: 10.1016/J.Ophtha.2006.08.008 |
0.51 |
|
| 2006 |
Thorne JE, Jabs DA, Kempen JH, Holbrook JT, Nichols C, Meinert CL. Causes of visual acuity loss among patients with AIDS and cytomegalovirus retinitis in the era of highly active antiretroviral therapy. Ophthalmology. 113: 1441-5. PMID 16781775 DOI: 10.1016/J.Ophtha.2006.03.022 |
0.519 |
|
| 2006 |
Thorne JE, Jabs DA, Kempen JH, Holbrook JT, Nichols C, Meinert CL. Incidence of and risk factors for visual acuity loss among patients with AIDS and cytomegalovirus retinitis in the era of highly active antiretroviral therapy. Ophthalmology. 113: 1432-40. PMID 16766032 DOI: 10.1016/J.Ophtha.2006.03.021 |
0.519 |
|
| 2003 |
Gilpin AM, Holbrook JT, Jabs DA, Meinert CL. Data and safety monitoring board deliberations resulting in the early termination of the Monoclonal Antibody Cytomegalovirus Retinitis Trial. Controlled Clinical Trials. 24: 92-8. PMID 12559647 DOI: 10.1016/S0197-2456(02)00268-4 |
0.528 |
|
| 2002 |
Davidson M, Min YI, Holbrook JT, Van Natta M, Quinn TC, Murphy RL, Welch W, Jabs DA, Meinert CL. Influence of filgrastim (granulocyte colony-stimulating factor) on human immunodeficiency virus type 1 RNA in patients with cytomegalovirus retinitis. The Journal of Infectious Diseases. 186: 1013-8. PMID 12232843 DOI: 10.1086/342956 |
0.484 |
|
| 2002 |
Davidson M, Min YI, Holbrook JT, Van Natta ML, Murphy R, Jabs DA, Welch W, Meinert CL. Use of filgrastim as adjuvant therapy in patients with AIDS-related cytomegalovirus retinitis. Aids (London, England). 16: 757-65. PMID 11964532 DOI: 10.1097/00002030-200203290-00011 |
0.494 |
|
| 2001 |
Holbrook JT, Meinert CL, Van Natta ML, Davis M, Hubbard L, Jabs DA. Photographic measures of cytomegalovirus retinitis as surrogates for visual outcomes in treated patients Archives of Ophthalmology. 119: 554-563. PMID 11296021 |
0.53 |
|
| 2001 |
Holbrook JT, Meinert CL, Jabs DA. Patient notification and follow-up after suspension of treatment protocols: Experience from four clinical trials of treatments for AIDS-related CMV retinitis Controlled Clinical Trials. 22: 62-68. PMID 11165425 DOI: 10.1016/S0197-2456(00)00112-4 |
0.562 |
|
| 2000 |
Holbrook JT, Davis MD, Hubbard LD, Martin BK, Holland GN, Jabs DA, Gilpin AK, Meinert C, Reshef DS. Risk factors for advancement of cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome Archives of Ophthalmology. 118: 1196-1204. PMID 10980764 DOI: 10.1001/archopht.118.9.1196 |
0.529 |
|
| 1996 |
Wu AW, Coleson LC, Holbrook J, Jabs DA. Measuring Visual Function and Quality of Life in Patients With Cytomegalovirus Retinitis: Development of a Questionnaire Archives of Ophthalmology. 114: 841-847. PMID 8660168 DOI: 10.1001/Archopht.1996.01100140055008 |
0.342 |
|
| 1994 |
Holbrook JT, Meinert CL, Gilpin AK. 95P On the likelihood of finding subgroup differences in clinical trials Controlled Clinical Trials. 15: 129-130. DOI: 10.1016/0197-2456(94)90223-2 |
0.527 |
|
| 1993 |
Holbrook JT, Meinert CL. A21 Principles of agreement for post NDA clinical trials Controlled Clinical Trials. 14: 407. DOI: 10.1016/0197-2456(93)90087-T |
0.504 |
|
| 1992 |
Holbrook JT, Meinert CL. Crisis management: A coordinating center's experience with the suspension of a aids treatment protocol for a clinical trial Controlled Clinical Trials. 13: 394. |
0.517 |
|
| 1991 |
Holbrook JT, Meinert CL. Advantages and disadvantages of treatment preference designs for clinical trials Controlled Clinical Trials. 12: 622. DOI: 10.1016/0197-2456(91)90082-W |
0.531 |
|
| Show low-probability matches. |